Viewing Study NCT06342960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-03-05 @ 7:36 AM
Study NCT ID: NCT06342960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-29
First Post: 2024-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
Sponsor: Kyverna Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Nephritis View
None Lupus Nephritis - WHO Class III View
None Lupus Nephritis - WHO Class IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KYV-101 View
None glomerulonephritis View
None autoimmune disease View
None anti-CD19 CAR-T therapy View
None cellular therapy View
None SLE View
None Systemic lupus erythematosus View